NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ:
Post# of 174
(Total Views: 222)
Posted On: 04/28/2020 3:55:41 PM
NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Engagement of MZ Group to Expand Strategic Communications Program Across Key Markets
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced its engagement of international investor relations specialists MZ Group (“MZ”) to expand its comprehensive strategic investor relations and financial communications program across all key markets. According to the update, MZ Group will work closely with Trxade Group management in the development and implementation of a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment community. “This is an exciting time for Trxade Group, having achieved key growth milestones in 2019, positioning us for a breakout year in 2020 as we continue to scale our proprietary platform,” Trxade Group chairman and CEO Suren Ajjarapu said in the news release. “The importance of our trading platform has been validated by the market, having grown our footprint of registered independent pharmacy members to 40% in 2019 to over 12,100 locations nationwide. These pharmacies have seen purchasing efficiencies on our platform before and during the COVID-19 pandemic, as we uniquely positioned to supply COVID-19 test kits in time to make a difference in the lives of their patients. Together with MZ Group, we will enhance our investor communications and awareness efforts, while simultaneously working to create sustainable value for our shareholders over the long-term.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Trxade Group, Inc. (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced its engagement of international investor relations specialists MZ Group (“MZ”) to expand its comprehensive strategic investor relations and financial communications program across all key markets. According to the update, MZ Group will work closely with Trxade Group management in the development and implementation of a comprehensive capital markets strategy designed to increase the Company’s visibility throughout the investment community. “This is an exciting time for Trxade Group, having achieved key growth milestones in 2019, positioning us for a breakout year in 2020 as we continue to scale our proprietary platform,” Trxade Group chairman and CEO Suren Ajjarapu said in the news release. “The importance of our trading platform has been validated by the market, having grown our footprint of registered independent pharmacy members to 40% in 2019 to over 12,100 locations nationwide. These pharmacies have seen purchasing efficiencies on our platform before and during the COVID-19 pandemic, as we uniquely positioned to supply COVID-19 test kits in time to make a difference in the lives of their patients. Together with MZ Group, we will enhance our investor communications and awareness efforts, while simultaneously working to create sustainable value for our shareholders over the long-term.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)